Several ceria‐zirconia supported mono and bi‐metallic transition metal oxide clusters containing Fe, Cu, and Ni are synthesized by dry impregnation. Through XRD, H2‐TPR, NH3‐TPD, pyridine adsorption followed by FTIR spectroscopy and XAS, the well‐dispersed nature of the transition metal oxide clusters is revealed, and the Lewis acidity of the catalysts is assessed. In‐situ FTIR spectroscopy is used to monitor the methane activation on catalyst surfaces. All catalysts activate methane at 250 °C forming methyl, alkyl, and methoxy species on the catalyst surface. By co‐feeding steam and oxygen together with methane, continuous direct oxidation of methane to methanol can be achieved, with the complete oxidation to CO2 as the other reaction path. Methoxy species are found to be a key intermediate for methanol production. Lowering the methane conversion improves the methanol selectivity. By extrapolation, it is estimated that methanol selectivity close to unity can be achieved below a threshold of methane conversion at about 0.002 %. The formation of CuO and NiO mixed metal oxides produces stronger Lewis acid sites and yields higher methanol selectivity.

No abstract

No abstract

IntroductionWe successfully developed a broad spectrum of patient-derived endocrine organoids (PDO) from benign and malignant neoplasms of thyroid, parathyroid, and adrenal glands. In this study, we employed functionally intact parathyroid PDOs from benign parathyroid tissues to study primary hyperparathyroidism (PHPT), a common endocrine metabolic disease. As proof of concept, we examined the utility of parathyroid PDOs for bioenergetic and metabolic screening and assessed whether parathyroid PDO metabolism recapitulated matched PHPT tissues.MethodsOur study methods included a fine-needle aspiration (FNA)-based technique to establish parathyroid PDOs from human PHPT tissues (n=6) in semi-solid culture conditions for organoid formation, growth, and proliferation. Mass spectrometry metabolomic analysis of PHPT tissues and patient-matched PDOs, and live cell bioenergetic profiling of parathyroid PDOs with extracellular flux analyses, were performed. Functional analysis cryopreserved and re-cultured parathyroid PDOs for parathyroid hormone (PTH) secretion was performed using ELISA hormone assays.Results and discussionOur findings support both the feasibility of parathyroid PDOs for metabolic and bioenergetic profiling and reinforce metabolic recapitulation of PHPT tissues by patient-matched parathyroid PDOs. Cryopreserved parathyroid PDOs exhibited preserved, rapid, and sustained secretory function after thawing. In conclusion, successful utilization of parathyroid PDOs for metabolic profiling further affirms the feasibility of promising endocrine organoid platforms for future metabolic studies and broader multiplatform and translational applications for therapeutic advancements of parathyroid and other endocrine applications.